Eph receptor tyrosine kinases have been implicated in various developmental processes, including axonal guidance, angiogenesis and morphogenesis. In general, Eph receptors and their ligands, ephrins, are reciprocally compartmentalized during embryogenesis. However, they are expressed in an overlapping fashion in some developing neural and non-neural tissues. Results from the overexpression or mutant mice of ephrin ligands in the retino-tectal system suggest that ephrin-As regulate co-expressed EphA receptor activity, but little is known about the molecular mechanisms. Here we show that EphA receptors and co-expressed ephrin-A ligands interact directly in cis via their functional binding domains, and that this interaction does not seem to mediate intracellular signals, but has an inhibitory effect on the trans interaction.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neures.2003.11.009DOI Listing

Publication Analysis

Top Keywords

epha receptor
8
receptor tyrosine
8
tyrosine kinases
8
co-expressed ephrin-a
8
ephrin-a ligands
8
kinases interact
4
interact co-expressed
4
ligands
4
ligands cis
4
cis eph
4

Similar Publications

Understanding the early interactions between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and human airway epithelial cells is essential for unraveling viral replication and spread mechanisms. In this study, we investigated the early dynamics of airway epithelial cells during SARS-CoV-2 infection using well-differentiated human nasal and tracheal epithelial cell cultures by incorporating three publicly available single-cell RNA sequencing datasets. We identified a previously uncharacterized cell population, termed virus-rich intermediate (VRI) cells, representing an intermediate differentiation stage between basal and ciliated cells.

View Article and Find Full Text PDF

EFNA4-enhanced deubiquitination of SLC7A11 inhibits ferroptosis in hepatocellular carcinoma.

Apoptosis

December 2024

Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, 510315, China.

Article Synopsis
  • EFNA4 influences liver cancer (HCC) through two mechanisms: one that binds to Eph receptors and another that operates independently of them.
  • Despite a lack of Eph receptors, EFNA4 still promotes HCC cell growth and spread as well as inhibiting ferroptosis, a type of cell death.
  • The study reveals that EFNA4 interacts with the protein SLC7A11 to prevent its degradation, enhancing HCC progression and suggesting EFNA4 as a potential marker and target for HCC treatment.
View Article and Find Full Text PDF

Constrained β-Hairpins Targeting the EphA4 Ligand Binding Domain.

J Med Chem

December 2024

Division of Biomedical Sciences, School of Medicine, University of California Riverside, 900 University Avenue, Riverside, California 92521, United States.

The activity of the receptor tyrosine kinase EphA4 has been implicated in several pathologies including oncology (gastric and pancreatic cancers) and neurodegenerative diseases (amyotrophic lateral sclerosis and Alzheimer's disease). However, advances in validating EphA4 as a possible drug target have been limited by the lack of suitable pharmacological inhibitors. Recently, we reported on the design of potent EphA4 agonistic agents targeting its ligand binding domain (LBD).

View Article and Find Full Text PDF
Article Synopsis
  • Hidden biases in non-randomized studies challenge the identification of causal protein biomarkers for Alzheimer's disease, and traditional methods can lead to misleading results.
  • The MR-SPI method enhances Mendelian randomization by selecting valid pQTL instruments, addressing some of these biases and integrating structural predictions from AlphaFold3.
  • Using data from over 500,000 individuals, researchers identified seven proteins with structural changes linked to Alzheimer's, contributing to understanding the disease's causes and potential treatment targets.
View Article and Find Full Text PDF

Receptor tyrosine kinases (RTKs) regulate many cellular functions and are important targets in pharmaceutical development, particularly in cancer treatment. EGFR and EphA2 are two key RTKs that are associated with oncogenic phenotypes. Several studies have reported functional interplay between these receptors, but the mechanism of interaction is still unresolved.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!